Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre

被引:20
作者
Liao, S. [1 ,2 ]
Cai, C. [2 ]
Huo, F-M. [1 ,2 ]
Wu, J-N. [1 ,2 ]
Kong, C-C. [1 ,2 ]
Huang, H-R. [1 ,2 ]
Xu, S-F. [1 ,2 ]
Sun, Z-G. [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Chest Hosp, Natl TB Clin Lab, Beijing, Peoples R China
[2] Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistant TB Res, 9 Beiguan St, Beijing 101149, Peoples R China
关键词
tuberculosis; prevalent tendency; multi drug resistance; extensive drug resistance; PUBLIC-HEALTH SYSTEM; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; NATIONAL-SURVEY; PULMONARY; PATTERN;
D O I
10.5588/ijtld.17.0086
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
OBJECTIVE: To describe the trends in prevalence of drug-resistant tuberculosis (TB) among in-patients in Beijing Chest Hospital, Beijing, China, using a 10-year retrospective study. DESIGN: From 2005 to 2014, 18 310 in-patients with TB were recruited for the study, most of whom were referrals; no distinction was made between new and previously treated cases. Drug susceptibility testing (DST) was performed in culture-positive cases using the proportion method to determine multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). Risk factors associated with drug resistance were identified. RESULTS: A total of 5141 (28.0%) samples were culture-positive. DST results showed that 860 (16.7%) cases were MDR-TB and 176 (3.4%) were XDR-TB. MDR-TB and XDR-TB were detected in respectively 21.2% and 12.5% of new cases. The rate of MDR-TB and XDR-TB gradually increased from 2005, with MDR-TB reaching a peak in 2008 and XDR-TB in 2009. These data closely mirror national survey data on this region, patient age and occupation. CONCLUSION: Trends in MDR-TB and XDR-TB prevalence during the past decade and their inflection points were determined, which complemented reports from previous national surveys. This information is useful for fighting TB in China.
引用
收藏
页码:990 / 995
页数:6
相关论文
共 26 条
[1]  
[Anonymous], 2013, EURO SURVEILL
[2]  
[Anonymous], J BIOMED SCI RES
[3]  
[Anonymous], 2015, GLOBAL TUBERCULOSIS
[4]  
Chen Cheng Chen Cheng, 2013, Disease Surveillance, V28, P265
[5]   World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update [J].
Falzon, Dennis ;
Schunemann, Holger J. ;
Harausz, Elizabeth ;
Gonzalez-Angulo, Lice ;
Lienhardt, Christian ;
Jaramillo, Ernesto ;
Weyer, Karin .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
[6]  
Farazi A, 2013, CASP J INTERN MED, V4, P785
[7]   Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center [J].
Lee, Ho Young ;
Lee, Jin ;
Lee, Young Seok ;
Kim, Mi-Yeong ;
Lee, Hyun-Kyung ;
Lee, Young-Min ;
Shin, Jeong Hwan ;
Ko, Yousang .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (03) :325-334
[8]   Rates and risk factors for drug resistance tuberculosis in Northeastern China [J].
Liu, Qiao ;
Zhu, Limei ;
Shao, Yan ;
Song, Honghuan ;
Li, Guoli ;
Zhou, Yang ;
Shi, Jinyan ;
Zhong, Chongqiao ;
Chen, Cheng ;
Lu, Wei .
BMC PUBLIC HEALTH, 2013, 13
[9]   Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling [J].
Liu, Yun-Xia ;
Pang, Chun-Kun ;
Liu, Yanxun ;
Sun, Xiu-Bin ;
Li, Xin-Xu ;
Jiang, Shi-Wen ;
Xue, Fuzhong .
PLOS ONE, 2015, 10 (05)
[10]  
Ministry of Health of the People's Republic of Chinese, 2010, NAT SURV DRUG RES TU